
Utah Could Become the First State to Ban Fluoride in Public Water
Utah could soon become the first U.S. state to ban the addition of fluoride to drinking water.
On Friday, the Utah State Senate approved a bill that prohibits adding the mineral to public water systems. If signed by Governor Spencer Cox, the measure would go into effect on May 7. The governor has not publicly commented on whether he supports the bill.
The passage of the Utah bill comes roughly two weeks after the confirmation of Robert F. Kennedy, Jr., as health secretary. In November, Mr. Kennedy vowed that the Trump administration would 'advise all U.S. systems to remove fluoride from public water.'
In 2022, about 44 percent of Utah residents supplied with public drinking water were drinking fluoridated water. Fluoride is added to drinking water because it prevents cavities, a benefit first observed over a century ago. The Centers for Disease Control and Prevention has heralded water fluoridation as one of the 10 greatest public health achievements of the 20th century.
'The evidence that addition of fluoride to the water reduces cavities and tooth decay is unequivocal,' said Dr. F. Perry Wilson, a physician and chronic disease epidemiologist at the Yale School of Medicine.
Opponents of water fluoridation, including Mr. Kennedy and Utah State Representative Stephanie Gricius, who introduced the bill, argue that the chemical could have harmful neurological effects on fetuses and young children. In a recent review paper, researchers with the National Institutes of Health analyzed the results of 74 studies and concluded that high levels of prenatal or childhood fluoride exposure were linked with lower IQ scores in childhood.
However, the fluoride levels associated with lower IQ scores were twice as high as the water fluoridation levels recommended by the C.D.C. Typically, high levels of fluoride exposure are associated not with community water fluoridation, Dr. Wilson said, but with natural fluoride contamination from water running over rocks and soil.
And some other studies have found no link between fluoride and IQ.
'There is still no evidence that community water fluoridation, with the fluoride levels used in the United States, is associated with any adverse health effects,' said Dr. Scott Tomar, a public health dentist and oral epidemiologist at the University of Illinois Chicago College of Dentistry.
This does not mean such a link could not exist. Among other things, no large, longitudinal studies on the relationship between water fluoridation and IQ have been conducted in the United States.
'We must always be on the lookout for new data and allow that to change our conclusions,' Dr. Wilson said.
And there is no question that some Americans are exposed to higher than recommended levels of fluoride in their drinking water because of natural fluoride contamination. In a 2020 study, researchers analyzed water samples from private wells around the nation. They found that the water in some wells was naturally contaminated with fluoride at levels above four milligrams per liter, the legal fluoride limit for drinking water. That is more than 2.5 times the level at which effects on IQ have been observed.
The new Utah law would ban manually adding fluoride to public water, but it would not apply to well water, nor would it reduce the amount of fluoride residents might be exposed to from natural sources.
'This law would have zero effect on that,' Dr. Tomar said.
Other states and U.S. cities and counties are considering or have implemented similar bans. This month, a bill banning water fluoridation was introduced into the Montana state legislature, though that measure was set aside by a committee on February 25. Some communities in North Carolina, Oregon, and Pennsylvania have recently ceased fluoridation. And lawmakers in other states have filed bills that would leave the decision to fluoridate up to voters or local governing bodies.
Research suggests that fluoridation bans could have negative ramifications for oral health. A 2018 study found that children in the U.S. without access to fluoridated water developed 39 percent more cavities in their baby teeth, and 16 percent more cavities in their permanent teeth, than children in communities where most people had access to fluoridated water.
Dr. Wilson worried, too, that the law would have the largest effect on low-income residents. 'Fluoridation of the water supply has disproportionate benefit to those of lower socioeconomic status, with less access to preventative dental care,' he said. 'This bill will hurt those Utahans most.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Miami Herald
8 minutes ago
- Miami Herald
CDC warns of deadly disease outbreak in key cruise ports
Before you travel, it's always a good idea to review country-specific health information provided by the Centers for Disease Control and Prevention (CDC), as well as travel safety information provided by the U.S. State Department. These notices and travel advisories provide important information to help U.S. citizens guard their health and safety while traveling abroad - whether on a cruise or another type of trip. Related: US changes travel threat level for controversial Caribbean port Although travelers often focus more attention on destination-specific safety and security threats outlined in travel advisories, it's important to consider travel health notices, too. The CDC recently updated some of these notices, including a vital warning for travelers concerning outbreaks of dengue, a common mosquito-borne disease that can have life-threatening health consequences in some cases. More than 13 million cases of dengue were reported across the Americas and in the Caribbean in 2024, and dengue outbreaks in these areas continue in 2025. Sign up for the Come Cruise With Me newsletter to save money on your next (or your first) cruise. The CDC recently updated its travel health notice about global dengue, warning travelers that a number of countries around the world continue to report increased numbers of cases of the serious disease. In its notice, the CDC also explains that health officials are seeing a concerning rise in the number of dengue cases among U.S. travelers returning from certain countries. Dengue outbreaks are reported regularly in many popular tourist destinations, including cruise ports, in the Caribbean, Central America, South America, Southeast Asia, and the Pacific Islands. Related: Royal Caribbean shares new health warning for cruisepassengers Specific countries currently experiencing dengue outbreaks include: BrazilColombiaComorosCubaEcuador, including the Galápagos IslandsFijiFrench Polynesia, including the island groups of Society Islands (Tahiti, Moorea, and Bora-Bora)Marquesas Islands (Hiva Oa and Ua Huka)Austral Islands (Tubuai and Rurutu)GuadeloupeGuatemalaIranMexicoPakistanPanamaPhilippinesSaint LuciaSamoaSudan, and Tonga. Public health officials in Puerto Rico and the U.S. Virgin Islands have also declared dengue outbreaks. If you're taking a cruise to Puerto Rico, the Virgin Islands, Mexico, Panama, or Saint Lucia, you should be especially careful and take steps to protect yourself from dengue. Be the first to see the best deals on cruises, special sailings, and more. Sign up for the Come Cruise With Me newsletter. Dengue is caused by a virus that's spread by mosquito bites, so the CDC advises travelers visiting risk areas to be diligent about preventing them. The CDC's recommendations for mosquito bite prevention include: Use an Environmental Protection Agency (EPA)-registered insect repellentWear long-sleeved shirts and long pants when outdoorsSleep in an air-conditioned room or room with window screens If you do get mosquito bites during a cruise or other trip to a destination with a dengue risk, there are a few things to know and key symptoms to look out for following your trip. Dengue can take up to two weeks to begin, and illness generally lasts less than a week. Symptoms include fever, headache, nausea, vomiting, rash, muscle and joint pain, and minor bleeding. If you develop a fever or experience other symptoms of dengue, you should see a health care provider and inform them of your travel. Related: CDC says throw this food out after salmonella sickens cruisers In some cases, dengue can become severe within a few hours, quickly turning into a medical emergency that typically requires hospitalization. Severe dengue can lead to hemorrhage (uncontrolled bleeding), shock (seriously low blood pressure), organ failure, and even death. Even if you don't get sick, if you've recently visited a dengue risk area, you should also continue protect yourself from mosquito bites upon your return home to reduce the chance of spreading dengue. The CDC advises that travelers returning from a destination with a dengue risk should take steps to prevent mosquito bites for three weeks in order to avoid spreading dengue to mosquitoes that could spread the virus to other people. (The Arena Group will earn a commission if you book a cruise.) Make a free appointment with Come Cruise With Me's Travel Agent Partner, Postcard Travel, or email Amy Post at amypost@ or call or text her at 386-383-2472. Copyright 2025 The Arena Group, Inc. All Rights Reserved
Yahoo
19 minutes ago
- Yahoo
Joe Biden 'optimistic' about treatment plan for Stage 4 prostate cancer
Former President Joe Biden said on May 30 that he is 'optimistic' about the treatment plan for his Stage 4 prostate cancer, which involves taking a daily pill for six weeks. "We're underway and all the folks are very optimistic," Biden said. 'The expectation is we're going to be able to beat this. It's not in any (other) organ. My bones are strong, it hasn't penetrated. So I'm feeling good.' More: Biden urges Americans to support veterans on anniversary of son Beau's death Doctors found a 'small nodule' on Biden's prostate during a routine exam; the 82-year-old was diagnosed Friday, May 16, according to a statement released by his office. Speaking to reporters at a Delaware Memorial Day event for the first time since announcing his diagnosis, Biden said that he is being treated by a top doctor in the field. Biden's physician has lived through the same aggressive form of cancer as the former president. 'We're all optimistic about the diagnosis. Matter of fact, one of the leading surgeons in the world is working with me and he was diagnosed with the same exact thing 32 years ago,' Biden said. 'He's alive and well, doing very well.' Biden spoke with reporters as he left the annual Memorial Day event at Veterans Memorial Park in New Castle, Delaware, which coincided with the 10th anniversary of his son Beau Biden's death. It was also the first time Biden spoke to reporters since a book was published raising questions about his physical and mental fitness while he was president. A White House spokeswoman alleged Thursday that former first lady Jill Biden conspired to keep her husband's health from the American people. When asked to respond, Biden, who had just given a 10-minute speech and walked over to the throng of reporters, joked, "You can see that I'm mentally incompetent and I can't walk." This article originally appeared on USA TODAY: Joe Biden 'optimistic' about cancer treatment, doctor, meds
Yahoo
29 minutes ago
- Yahoo
California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone
California and three other states petitioned the U.S. Food and Drug Administration Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's proven safety record and arguing the new limits are unnecessary. "The medication is a lifeline for millions of women who need access to time-sensitive, critical healthcare — especially low-income women and those who live in rural and underserved areas," said California Atty. Gen. Rob Bonta, who filed the petition alongside the attorneys general of Massachusetts, New York and New Jersey. The petition cites Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. last month, in which Kennedy said he had ordered FDA administrator Martin Makary to conduct a "complete review" of mifepristone and its labeling requirements. The drug, which can be received by mail, has been on the U.S. market for 25 years and taken safely by millions of Americans, according to experts. It is the most common method of terminating a pregnancy in the U.S., with its use surging after the Supreme Court overturned Roe vs. Wade in 2022. The Supreme Court upheld access to the drug for early pregnancies under previous FDA regulations last year, but it has remained a target of anti-abortion conservatives. The Trump administration has given Kennedy broad rein to shake up American medicine under his "Make America Healthy Again" banner, and Kennedy has swiftly rankled medical experts by using dubious science — and even fake citations — to question vaccine regimens and research and other longstanding public health measures. Read more: Hiltzik: MAHA report's misrepresentations will harm public health and hit consumers' pocketbooks At the Senate hearing, Kennedy cited "new data" from a flawed report pushed by anti-abortion groups — and not published in any peer-reviewed journal — to question the safety of mifepristone, calling the report "alarming." "Clearly, it indicates that, at very least, the label should be changed," Kennedy said. Sen. Josh Hawley (R-Mo.) on Monday posted a letter from Makary to X, in which Makary wrote that he was "committed to conducting a review of mifepristone" alongside "the professional career scientists" at the FDA. Makary said he could not provide additional information given ongoing litigation around the drug. The states, in their 54-page petition, wrote that "no new scientific data has emerged since the FDA's last regulatory actions that would alter the conclusion that mifepristone remains exceptionally safe and effective," and that studies "that have frequently been cited to undermine mifepristone's extensive safety record have been widely criticized, retracted, or both." Democrats have derided Kennedy's efforts to reclassify mifepristone as politically motivated and baseless. "This is yet another attack on women's reproductive freedom and scientifically-reviewed health care," Gov. Gavin Newsom said the day after Kennedy's Senate testimony. "California will continue to protect every person's right to make their own medical decisions and help ensure that Mifepristone is available to those who need it." Bonta said Thursday that mifepristone's placement under the FDA's Risk Evaluation and Mitigation Strategy program for drugs with known, serious side effects — or REMS — was "medically unjustified," unduly burdened patient access and placed "undue strain on the nation's entire health system." He said mifepristone "allows people to get reproductive care as early as possible when it is safest, least expensive, and least invasive," is "so safe that it presents lower risks of serious complications than taking Tylenol," and that its long safety record "is backed by science and cannot be erased at the whim of the Trump Administration." Read more: Q&A: The FDA says the abortion pill mifepristone is safe. Here's the evidence The FDA has previously said that fewer than 0.5% of women who take the drug experience 'serious adverse reactions,' and deaths are exceedingly rare. The REMS program requires prescribers to add their names to national and local abortion provider lists, which can be a deterrent for doctors given safety threats, and pharmacies to comply with complex tracking, shipping and reporting requirements, which can be a deterrent to carrying the drug, Bonta said. It also requires patients to sign forms in which they attest to wanting to "end [their] pregnancy," which Bonta said can be a deterrent for women using the drug after a miscarriage — one of its common uses — or for those in states pursuing criminal penalties for women seeking certain abortion care. Under federal law, REMS requirements must address a specific risk posed by a drug and cannot be "unduly burdensome" on patients, and the new application to mifepristone "fails to meet that standard," Bonta said. The states' petition is not a lawsuit, but a regulatory request for the FDA to reverse course, the states said. If the FDA will not do so nationwide, the four petitioning states asked that it "exercise its discretion to not enforce the requirements" in their states, which Bonta's office said already have "robust state laws that ensure safe prescribing, rigorous informed consent, and professional accountability." Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.